Invasive fungal infections in living unrelated renal transplantation

Transplantation Proceedings

Volumn 37, Issue 7, 2005, Pages 3034-3037

  Alkhunaizi, A M ^a   Amir, A A ^a   Al Tawfiq, J A ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CYCLOSPORIN; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POSACONAZOLE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; FEMALE; FUNGUS; HEMIPLEGIA; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVING DONOR; MALE; MUCORMYCOSIS; PRIORITY JOURNAL; RAMICHLORIDIUM MACKENZIEI; SEPSIS;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYCOSES; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26444571821     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.07.029     Document Type: Article

References (22)

1. J.A. Fishman, R.H. Rubin Infection in organ-transplant recipients N Engl J Med 338 1992 1741
2. H.M. AL-Abdely, A.M. Alkhunaizi, J.A. Al-Tawfiq Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole Med Mycol 43 2005 91
3. M.S. Sever, T. Ecder, A.E. Aydin Living unrelated (paid) kidney transplantation in third-world countries high risk of complications besides the ethical problem Nephrol Dial Transplant 9 1994 350
4. K.S. Chugh, V. Sakhuja, S. Jain High mortality in systemic fungal infections following renal transplantation in third-world countries Nephrol Dial Transplant 8 1993 168
5. Anonymous: Commercially motivated renal transplantation: results in 540 patients transplanted in India. The Living Non-Related Renal Transplant Study Group Clin Transplant 11 1997 536
6. K.M. Carbone, L.R. Pennington, L.F. Gimenez Mucormycosis in renal transplant patients-a report of two cases and review of the literature Q J Med 57 1985 825
7. G. Morduchowicz, D. Shmueli, Z. Shapira Rhinocerebral mucormycosis in renal transplant recipients report of three cases and review of the literature Rev Infect Dis 8 1986 441
8. A.H. Kaplan, E. Poza-Juncal, R. Shapiro Cure of mucormycosis in a renal transplant patient receiving ciclosporin with maintenance of immunosuppression Am J Nephrol 8 1988 139
9. A. Mitwalli, G.H. Malik, J. al-Wakeel Mucormycosis of the graft in a renal transplant recipient Nephrol Dial Transplant 9 1994 718
10. D.A. Sutton, M. Slifkin, R. Yakulis U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei) criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa J Clin Microbiol 36 1998 708
11. Naim-ur-Rahman, E.S. Mahgoub, A.H. Chagla Fatal brain abscesses caused by Ramichloridium obovoideum report of three cases Acta Neurochir (Wien) 93 1988 92
12. C.K. Campbell, S.S. al-Hedaithy Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries J Med Vet Mycol 27 1993 127
13. S.S. Kanj, S.S. Amr, G.D. Roberts Ramichloridium mackenziei brain abscess report of two cases and review of the literature Med Mycol 39 1997 97
14. Z.U. Khan, S.J. Lamdhade, M. Johny Additional case of Ramichloridium mackenziei cerebral phaeohyphomycosis from the Middle East Med Mycol 40 2002 429
15. T.F. Patterson, W.R. Kirkpatrick, M. White Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group Medicine (Baltimore) 79 2000 250
16. D.W. Denning, D.A. Stevens Antifungal and surgical treatment of invasive aspergillosis review of 2,121 published cases Rev Infect Dis 12 1990 1147
17. M. Ellis, D. Spence, B. de Pauw An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis Clin Infect Dis 27 1998 1406
18. D.W. Denning, J.Y. Lee, J.S. Hostetler NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis Am J Med 97 1994 135
19. T.B. Aliff, P.G. Maslak, J.G. Jurcic Refractory Aspergillus pneumonia in patients with acute leukemia successful therapy with combination caspofungin and liposomal amphotericin Cancer 97 2003 1025
20. D.P. Kontoyiannis, R. Hachem, R.E. Lewis Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies Cancer 98 2003 292
21. D. George, P. Miniter, V.T. Andriole Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis Antimicrob Agents Chemother 40 1996 86
22. K.L. Oakley, G. Morrissey, D.W. Denning Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus Antimicrob Agents Chemother 41 1997 1504